Remarkably, among all treatment groups, the cohort treated with targeted split Neo-2/15 (ɑPD-L1-Neo2A + ɑPD-L1-Neo2B) was the only one in which some mice achieved complete tumor remission. The gene discussed is CD274; the disease is neoplasm.